Leon Berard Center

Lyon 69373

2 studies enrolling now · 5 studies all time

What they study most

Dedifferentiated Liposarcoma, MF, Metastatic Castration-Resistant Prostate Cancer, Myelofibrosis, Non Small Cell Lung Cancer, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, Prostate Cancer

Studies at this site

• IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE) — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment — Running, not enrolling
• Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma — Stopped early
• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer — Completed